Post Operative Pain Following Pulpectomy Versus Pulpotomy in Primary Molars Wit Irreversible Pulpitis
Launched by MINIA UNIVERSITY · Mar 24, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how much pain children experience after two different dental procedures for a condition called irreversible pulpitis, which is a serious tooth problem affecting primary molars (the big teeth in the back of the mouth). The study will compare post-operative pain levels between two treatments: pulpotomy (removing part of the tooth's pulp) and pulpectomy (removing all of the pulp).
To participate in this trial, children must be healthy and have a primary tooth with irreversible pulpitis. They should also be cooperative during the dental procedures. Unfortunately, children who have any mental, physical, or medical issues, or who struggle to cooperate, won't be eligible. If your child qualifies and chooses to participate, they will receive one of the two treatments, and their pain levels will be monitored afterward. This research aims to help improve dental care for children facing this painful condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy individual
- • Has primary tooth with irreversible pulpitis
- • Cooperative child
- Exclusion Criteria:
- • Mentally, physically or medically compromised children
- • Uncooperative children
About Minia University
Minia University is a prestigious educational institution located in Egypt, dedicated to advancing medical research and clinical trials. With a commitment to fostering innovation and improving healthcare outcomes, the university collaborates with a diverse range of stakeholders, including healthcare professionals and researchers. Minia University aims to enhance clinical practices through rigorous research methodologies and ethical standards, contributing to the body of knowledge in the medical field while addressing local and global health challenges. The university's clinical trial initiatives are designed to evaluate new treatments and interventions, ensuring a positive impact on patient care and community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported